![]() | License: Creative Commons Attribution 4.0 PDF - Published Version (14MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-585418
- DOI to cite this document:
- 10.5283/epub.58541
Abstract
Intoduction: Identification of specific metabolome and lipidome profile of patients with primary sclerosing cholangitis (PSC) is crucial for diagnosis, targeted personalized therapy, and more accurate risk stratification. Methods: Nuclear magnetic resonance (NMR) spectroscopy revealed an altered metabolome and lipidome of 33 patients with PSC [24 patients with inflammatory bowel disease ...

Owner only: item control page